Roche Holding AG (RHHBF)

USD 303.32

(0.0%)

Gross Profit Summary of Roche Holding AG

  • Roche Holding AG's latest annual gross profit in 2023 was 44.08 Billion CHF , up 2.8% from previous year.
  • Roche Holding AG's latest quarterly gross profit in 2024 Q2 was 11.64 Billion CHF , down 0.0% from previous quarter.
  • Roche Holding AG reported a annual gross profit of 42.88 Billion CHF in annual gross profit 2022, down -0.63% from previous year.
  • Roche Holding AG reported a annual gross profit of 43.15 Billion CHF in annual gross profit 2021, up 2.39% from previous year.
  • Roche Holding AG reported a quarterly gross profit of 11.64 Billion CHF for 2024 Q1, down -43.64% from previous quarter.
  • Roche Holding AG reported a quarterly gross profit of 44.08 Billion CHF for 2023 FY, up 2.8% from previous quarter.

Annual Gross Profit Chart of Roche Holding AG (2023 - 1998)

Historical Annual Gross Profit of Roche Holding AG (2023 - 1998)

Year Gross Profit Gross Profit Growth
2023 44.08 Billion CHF 2.8%
2022 42.88 Billion CHF -0.63%
2021 43.15 Billion CHF 2.39%
2020 42.14 Billion CHF -2.25%
2019 43.11 Billion CHF 8.94%
2018 39.57 Billion CHF 12.69%
2017 35.12 Billion CHF 2.1%
2016 34.39 Billion CHF 5.23%
2015 32.68 Billion CHF -4.1%
2014 34.08 Billion CHF -2.16%
2013 34.83 Billion CHF 4.53%
2012 33.32 Billion CHF 8.94%
2011 30.58 Billion CHF -10.51%
2010 34.18 Billion CHF -0.74%
2009 34.43 Billion CHF 7.76%
2008 31.95 Billion CHF -1.34%
2007 32.39 Billion CHF 3.07%
2006 31.42 Billion CHF 19.91%
2005 26.2 Billion CHF 8.78%
2004 24.09 Billion CHF 5.18%
2003 22.9 Billion CHF 7.57%
2002 21.29 Billion CHF 2.25%
2001 20.82 Billion CHF 6.74%
2000 19.5 Billion CHF 4.37%
1999 18.69 Billion CHF 11.53%
1998 16.76 Billion CHF 0.0%

Peer Gross Profit Comparison of Roche Holding AG

Name Gross Profit Gross Profit Difference
AstraZeneca PLC 34.69 Billion USD -27.068%
Bristol-Myers Squibb Company PFD CONV 2 34.31 Billion USD -28.476%
CSPC Pharmaceutical Group Limited 30.13 Billion USD -46.273%
Clarus Therapeutics Holdings, Inc. 11.23 Million USD -392211.115%
Novartis AG 34.18 Billion USD -28.946%
PT Kalbe Farma Tbk. 743.47 Million USD -5829.468%